NIH Indirect Cost Policy Shift

This chapter analyzes the recent NIH policy change that drastically reduces indirect cost payments from 50-60% to only 15%, impacting funding for universities and research institutions. It covers the ensuing backlash, potential lawsuits, and the implications for research viability, healthcare services, and the future of medical advancements.